Frontlight ResearchEarly access
Trial site
Barnet Dulaney Perkins Eye Center
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration4 trials
- Phase
- Phase 33 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- 4D Molecular Therapeutics1 trial
- AbbVie1 trial
- Stealth BioTherapeutics Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Closed trials
Terminated
Completed
Completed
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
Site data: ClinicalTrials.govUpdated 15 Nov 2026